Sun Pharma will Need HC Nod for Semaglutide Tablet Launch
Novo Nordisk submitted that a restraint order was required as Sun Pharma was ready to launch semaglutide tablets in the market the moment it would have marketing approval. And once…
Sun-Ranbaxy $4 billion merger completed
NEW DELHI: Almost a year after announcing a $4 billion deal, Sun Pharmaceutical Industries today said merger of Ranbaxy with itself has been ‘consummated’ following receipt of requisite approvals. In…
Sun Pharma Q2 net profit rises 5% to Rs 2,375 crore
Sun Pharmaceutical Industries Ltd. reported second-quarter consolidated net profit grew 5% to Rs 2,375.5 crore from the year-earlier period. Gross sales at Rs 12,003 crore, grew 11.0% Year on Year…
